Glenmark Life Sciences Limited (GLS.NS) NSE

1,086.00

+1.65(+0.15%)

Updated at January 17 03:29PM

Currency In INR

Valuation

Market Cap96.19B
Enterprise Value93.35B
P/E Ratio38.7
PEG Ratio8.98
Price/Sales Ratio7.66
Price/Book Ratio5.24
Enterprise/Revenue7.41
Enterprise/EBITDA25.59

Fiscal Year

Fiscal YearMarch 31, 2024
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0.2
Operating Margin0.15

Management Effectiveness

Return On Assets0.11
Return On Equity0.14

Income Statement

Revenue22.83B
Revenue/Share141.82
Gross Profit12.43B
EBITDA6.86B
Net Income4.71B
Diluted EPS38.38

Balance Sheet

Total Cash5.3B
Total Cash/Share43.28
Total Debt159.77M
Total Debt/Equity0.01
Current Ratio4.52
Book Value Per Share207.22

Price History

52-Week Change23.62
52-Week High1,335.1
52-Week Low676.5
Moving Average 50 Days1,046.58
Moving Average 200 Days986.54

Statistics

Average Volume125,749
Shares Outstanding122.53M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A